Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v6-FR | Version v1-EN | |
---|---|---|
Language | French | English |
Date Updated | 2020-07-08 | 2019-09-30 |
Drug Identification Number | 02049988 | 02049988 |
Brand name | TENORETIC 100/25MG TAB | TENORETIC 100/25MG TAB |
Common or Proper name | atenolol / chlorthalidone | atenolol / chlorthalidone |
Company Name | ASTRAZENECA CANADA INC | ASTRAZENECA CANADA INC |
Ingredients | CHLORTHALIDONE ATENOLOL | CHLORTHALIDONE ATENOLOL |
Strength(s) | 25MG 100MG | 25MG 100MG |
Dosage form(s) | TABLET | TABLET |
Route of administration | ORAL | ORAL |
Packaging size | 100 tablets | 100 tablets |
ATC code | C07CB | C07CB |
ATC description | BETA BLOCKING AGENTS AND OTHER DIURETICS | BETA BLOCKING AGENTS AND OTHER DIURETICS |
Reason for discontinuation | Business reasons | Business reasons |
Anticipated discontinuation date | 2020-03-31 | |
Actual discontinuation date | 2020-03-26 | |
Remaining supply date | 2020-03-26 | 2020-03-31 |
Discontinuation status | Discontinued | To be discontinued |
Discontinuation decision reversal | no | no |
Tier 3 Status | No | No |
Information on remaining supply | ||
Company comments | Company decision to discontinue product confirmed June 2020 | |
Health Canada comments |